Core Viewpoint - Haosai (002963.SZ) has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation for suspected violations of information disclosure laws, which the company claims will not significantly impact its operations and management [1][4]. Summary by Sections Investigation Details - The CSRC has initiated an investigation into Haosai for suspected violations of information disclosure laws based on the Securities Law and the Administrative Penalty Law of the People's Republic of China [2]. - In August, Haosai disclosed that its controlling shareholder, Dai Baolin, was arrested for suspected unit bribery, and the company was under investigation for the same reason, leading to a warning letter from the Beijing Securities Regulatory Bureau [2]. Legal Consequences - On November 5, Haosai was sentenced for unit bribery, receiving a fine of 7 million yuan, while Dai Baolin was sentenced to three years in prison with a four-year probation and a fine of 3 million yuan [2]. - The prosecution later deemed the sentence for Dai Baolin as too lenient and decided to appeal [2]. Company Response - Haosai stated in its announcement that its business activities are currently operating normally and that the investigation will not have a significant impact on its operations and management [4]. - Legal experts have expressed skepticism regarding the company's assertion, suggesting that such claims are premature before the CSRC's conclusions [5]. Market Impact - The investigation by the CSRC is likely to negatively affect Haosai's market image and investor confidence, with potential administrative penalties introducing uncertainty to the company's financial status and business development [5]. - The company's statement may be an attempt to stabilize investor sentiment and prevent stock price fluctuations amid the ongoing investigation [5].

Group 1 - The core point of the news is that two companies, 聚石化学 and 豪尔赛, are under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [2][3] - 聚石化学 reported a revenue of 2.963 billion yuan for the first three quarters of 2025, a year-on-year decrease of 7.17%, and a net profit attributable to shareholders of 5.7684 million yuan, with a net loss of 24.5322 million yuan after deducting non-recurring gains and losses [2] - 豪尔赛 stated that its business operations are normal and that the investigation will not have a significant impact on its management [3] Group 2 - Next week, 38 stocks will face a total unlock market value of 21.678 billion yuan [4] - 南方航空 will have 804 million shares listed for circulation, with an unlock market value of 5.689 billion yuan [5] - 菲菱科思 will have 22 million shares listed for circulation, with an unlock market value of 1.871 billion yuan [6] Group 3 - Among the 38 stocks facing unlock, 6 stocks have a high unlock ratio exceeding 30%, including 必易微, 吉冈精密, 赛恩斯, and 菲菱科思 [8] - The average stock price of the 38 stocks has decreased by 8.22% since November, with 久其软件 showing the highest increase of 13.74% [9] - 6 stocks with reported losses in the first three quarters include 红太阳, 水发燃气, 中望软件, 生物谷, 久其软件, and 必易微, indicating higher unlock pressure [10]

Group 1 - The core point of the article is that both 聚石化学 (Jushi Chemical) and 豪尔赛 (Haosai) have received notices from the China Securities Regulatory Commission (CSRC) regarding investigations into alleged violations of information disclosure laws [2][4] - Jushi Chemical announced that it received a notice from the CSRC on November 21, 2025, indicating that the company is under investigation for suspected information disclosure violations [2] - The company stated that all its business activities are currently operating normally and it will actively cooperate with the CSRC's investigation while fulfilling its information disclosure obligations [4][6] Group 2 - Haosai also received a notice from the CSRC for suspected violations of information disclosure laws and will cooperate with the investigation [4][6] - The company confirmed that its business operations are proceeding normally and that the investigation will not have a significant impact on its management and operations [6]

Group 1 - Two A-share companies, Jushi Chemical and Haosai, have been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [1][5] - Jushi Chemical received a notice from the CSRC on November 21, 2025, regarding the investigation, and the company will cooperate with the regulatory body during this period [1][3] - Haosai also announced its investigation by the CSRC and stated that its business operations remain normal and orderly [5][7] Group 2 - Jushi Chemical reported a revenue of 987 million yuan for Q3 2025, a year-on-year decrease of 0.81%, with a net profit attributable to shareholders of 2.89 million yuan [3][4] - Haosai achieved a revenue of 1.07 billion yuan for Q3 2025, reflecting a year-on-year increase of 31.34%, and a net profit attributable to shareholders of 740.11 thousand yuan, a significant increase of 599.72% [7][8] - Jushi Chemical's main products include modified plastic particles, automotive profiles, optical materials, and flame retardants, while Haosai focuses on smart technology services in various sectors [3][7]

Core Points - Haosai has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure regulations [2][4] - The company's actual controller, Dai Baolin, has been arrested for alleged unit bribery, leading to further scrutiny of the company's operations [5][6] Group 1: Investigation Details - On November 21, Haosai announced it received a notice of investigation from the CSRC due to suspected information disclosure violations [2] - The investigation follows Dai Baolin's arrest by public security authorities for alleged unit bribery, which has raised concerns about the company's governance and internal controls [5][6] Group 2: Company Operations - Haosai stated that it will actively cooperate with the investigation and that its business operations are currently normal and orderly [4] - The company has been under negative scrutiny since December of the previous year, with regulatory bodies highlighting deficiencies in its information disclosure practices [5][6] Group 3: Regulatory Actions - The Beijing Securities Regulatory Bureau issued a warning letter to Haosai for failing to fulfill its information disclosure obligations [6][7] - The Shenzhen Stock Exchange also sent a regulatory letter to Haosai and its responsible personnel, urging strict compliance with relevant laws and regulations regarding information disclosure [8] Group 4: Company Profile - Haosai's main business includes precision stamping molds and metal structural components for new energy vehicles, fuel vehicles, energy storage equipment, and communication devices [8] - As of November 21, Haosai's stock price was reported at 16.21 yuan per share, with a total market value of 2.437 billion yuan [8]

Core Viewpoint - 聚石化学 and 豪尔赛 are both under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may impact their operations and investor confidence [1][5]. Company Overview - 聚石化学 specializes in the research, production, and sales of new chemical materials, with products including modified plastic particles, automotive profiles, optical materials, and flame retardants, among others [3]. - 豪尔赛 focuses on technology innovation, developing smart lighting, smart cultural tourism, and smart urban areas, along with a digital twin integration network platform [7]. Financial Performance - 聚石化学 reported a revenue of 986.58 million yuan for Q3 2025, a decrease of 0.81% year-on-year, with a net profit of 2.89 million yuan [4]. - 豪尔赛 achieved a revenue of 106.94 million yuan for Q3 2025, an increase of 31.34% year-on-year, with a net profit of 740.11 thousand yuan, reflecting a significant growth of 599.72% [8].

Core Viewpoint - Haosai (002963) has received a notice of investigation from the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, but the company asserts that its operations remain normal and orderly, and the investigation will not significantly impact its management and operations [1] Group 1 - On November 21, Haosai announced the receipt of the CSRC's "Notice of Investigation" [1] - The investigation is due to alleged violations of information disclosure regulations [1] - Haosai's stock price fell by 5.32% to 16.21 yuan at market close on the day of the announcement [1]

相关事件 格隆汇11月14日丨英皇娱乐酒店(00296.HK)宣布，公司将于2025年11月26日(星期三)举行董事会会议， 藉以(其中包括)批准刊发公司及其附属公司截至2025年9月30日止六个月之中期业绩公告，以及考虑会 否派发中期股息。 英皇娱乐酒店(00296.HK)拟11月26日举行董事会会议审批中期业绩 英皇娱乐酒店(00296.HK)：预计中期 净亏损收窄至不多于8000万港元 ...

承董事會命 英皇娛樂酒店有限公司 公司秘書 馮佩玲 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 (於百慕達註冊成立之有限公司) (股份代號: 296) 董事會會議日期 英皇娛樂酒店有限公司（「本公司」）董事會（「董事會」）宣佈，本公司將於 2025年11月26日（星期三）舉行董事會會議，藉以（其中包括）批准刊發本公司及其附 屬公司截至2025年9月30日止六個月之中期業績公告，以及考慮會否派發中期股息。 香港，2025年11月14日 於本公告日期，董事會成員為 : 獨立非執行董事: 楊万鋠先生 陳漢標先生 陳嬋玲女士 非執行董事: 陸小曼女士 （主席） 執行董事: 楊政龍先生 （副主席） 范敏嫦女士 ...

Core Viewpoint - Emperor Entertainment Hotel (00296) expects a significant reduction in net loss for the six months ending September 30, 2025, to not more than HKD 80 million, compared to HKD 226 million in 2024 [1] Financial Performance - The improvement in net loss is primarily due to a substantial decrease in the fair value loss of investment properties, which is expected to be not more than HKD 70 million, down from HKD 264 million in 2024 [1] - The board believes that the fair value loss is a non-cash item and will not have a direct impact on the group's cash flow [1]